Life science company Nanologica has received an order for its silica-based purification media NLAB Saga from a new customer in China. The customer is a large pharmaceutical manufacturer and the order is for evaluation of NLAB Saga in production scale.

"This is a very interesting customer for us as it is larger than some of the others we work with. Among other things, they manufacture GLP-1 analogs, which is where our products come in. We have been working with the customer for some time now and it is very positive that they want to go ahead and evaluate our silica on a production scale," comments CEO Andreas Bhagwani in a press release.

The order is worth $180,000 and will be delivered in the second quarter.